A strain of bacillus subtilis and use thereof in the co-production of nattokinase and vitamin k2
Patent Information
- Application Number
- TW114119787
- Authority / Receiving Office
- TW · TW
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2024-05-30
- Filing Date
- 2025-05-27
- Publication Date
- 2026-11-11
- Estimated Expiration
- 2045-05-26
AI Technical Summary
The industry of producing nattokinase using Bacillus subtilis faces low enzyme activity and high production costs due to varying enzyme activity levels, long fermentation cycles, and cumbersome purification processes, while vitamin K2 production is hindered by low yields and high costs.
A strain of Bacillus subtilis (RB4) is used for the co-production of nattokinase and vitamin K2, with a fermentation cycle of less than 40 hours, producing a rich enzyme system and high vitamin K2 content in the by-product sludge, allowing for efficient separation and low-cost production.
The strain RB4 achieves improved nattokinase enzyme activity and vitamin K2 yield, reducing production costs and overcoming the limitations of long fermentation cycles and inefficient separation processes.
Abstract
Description
[Technical Field]
[0001] This invention relates to the field of microbial technology, and in particular to a strain of Bacillus subtilis and its application in the co-production of nattokinase and vitamin K2. [Previous Technology]
[0002] Nattokinase is an alkaline serine protease secreted by Bacillus subtilis. It has a molecular weight of approximately 28 kDa and is a single-chain protein structure composed of 275 amino acid residues. Its molecular weight is much smaller than that of urokinase, streptokinase, and recombinant tissue plasminogen activator, making it easier for the human body to absorb. It can produce a strong thrombolytic effect in the body and has significant effects in the treatment and prevention of thrombosis. Compared with clinical plasminogen products such as urokinase and streptokinase, it has the advantages of long half-life, good safety, strong specificity, and oral administration.
[0003] Vitamin K2 is an important fat-soluble coagulation vitamin used to maintain the body's normal coagulation function. In addition, as an electron transport carrier in respiratory metabolism, vitamin K2 also participates in many important metabolic reactions in the body. It has many important physiological functions such as preventing and treating osteoporosis, arterial calcification, cardiovascular diseases, tumors and Parkinson's disease. It has the advantages of high affinity and long half-life in the human body.
[0004] Bacillus subtilis is a Gram-positive bacterium that can produce not only nattokinase and vitamin K2, but also various proteases, glucosylamylase, pyridine dicarboxylic acid, and bioactive peptides, among other physiologically active substances. When a thrombus forms in the human body, enzyme systems with serine protease activity can play a synergistic role in efficiently degrading the cross-linked fibrin that forms the thrombus backbone. The abundance of these related proteases is crucial for efficient thrombolysis. Since different Bacillus species produce proteases with significant differences in their enzyme systems, selecting appropriate strains and fermentation processes is critical to the effectiveness of nattokinase-related products.
[0005] Currently, the industry of producing nattokinase using Bacillus subtilis is in its development stage, mainly facing two problems: low enzyme activity and high cost. Regarding enzyme activity, most previously reported enzyme activities are below 500 FU / mL, which, overall, is significantly lower than the fermentation levels of nattokinase reported in Japanese literature. The content, temperature resistance, and acid resistance of nattokinase produced vary considerably depending on the strain and fermentation process, leading to the requirement for low-temperature freeze-drying for most strains, resulting in high production costs (high drying costs).
[0006] The main vitamin K2 producing strain is Bacillus subtilis. Previous reports indicated that the fermentation cycle of these strains was long, and the vitamin K2 yield was not ideal. Vitamin K2 is distributed both intracellularly and extracellularly in the fermentation broth. The highest reported total content is found in patent CN116536220A, which discloses a method for preparing Bacillus subtilis natto and a method for preparing vitamin K2, with a vitamin K content of 124 mg / L and a fermentation time of 120-140 h. The long fermentation cycle increases the risks of contamination and unstable product content. Combined with the low fermentation yield in the industry, this ultimately leads to a consistently high production cost for vitamin K2.
[0007] In addition, in the "Method for Co-producing Vitamin K2 and Nattokinase by Fermentation using Bacillus natto" disclosed in patent CN106701719A, both nattokinase and vitamin K2 are in the fermentation supernatant. A complicated purification process is required to separate the two, and the fermentation level is low, resulting in insufficient production efficiency and failing to fundamentally solve the problem of generally high production costs of vitamin K2. [Summary of the Invention]
[0008] In view of this, the present invention provides a strain of Bacillus subtilis and its application in the co-production of nattokinase and vitamin K2. This strain achieves simultaneous fermentation of nattokinase and vitamin K2, produces a rich enzyme system of proteases, has a short fermentation cycle, and the fermentation broth is mainly used to produce nattokinase-related products, while the separated heavy phase (bacterial sludge) is mainly used to produce vitamin K2-related products.
[0009] This invention isolated a strain RB4 from the traditional Baijiu cellar mud in Yibin, Sichuan. The strain has the number AMCC 11927 in the Angel Yeast Co., Ltd. strain bank. It was identified as Bacillus subtilis by morphology and 16S rDNA. It was deposited at the Food Industry Development Institute Foundation in 2025 with the accession number CCTCC NO: M 2024343 (and deposited at the China Center for Type Culture Collection on February 27, 2024, at Wuhan University, Wuhan, China, with the accession number CCTCC NO: M 2024343).
[0010] The present invention also provides a microbial inoculant, including at least one of the Bacillus subtilis RB4 or its culture, metabolites and ferments.
[0011] The present invention also provides the use of the Bacillus subtilis RB4 or the microbial agent in at least one of the following aspects: (I) the use in the preparation of nattokinase and / or vitamin K2 or products thereof; (II) the use in the preparation of fermented soybeans, natto or intestinal probiotic agents; (III) the use in the fermentation preparation of biological feed.
[0012] In the above applications, the product includes at least one of natto, natto powder, nattokinase fermentation product, and microvitamin K2 fermentation product.
[0013] The present invention also provides a culture medium for fed-bacterial fermentation of Bacillus subtilis, comprising a fermentation base water culture medium and a feed; the fermentation base water culture medium comprises: corn flour, soybean meal, yeast peptone, L-serine, glycine, and inorganic salts; the inorganic salts comprise sodium salts, calcium salts, potassium salts, magnesium salts, zinc salts, and iron salts; the feed comprises feed 1, feed 2, and feed 3; feed 1 comprises water and a component selected from any combination of the following: a combination of liquefied corn flour and L-serine, a combination of maltodextrin and L-serine, a combination of corn flour and L-serine, and a combination of glycerol and L-serine; feed 2 comprises water and soybean meal, or an aqueous solution of ammonium sulfate; feed 3 comprises ammonia water.
[0014] In some embodiments, the inorganic salt includes sodium chloride, calcium chloride, potassium dihydrogen phosphate, magnesium sulfate, zinc sulfate and ferrous sulfate.
[0015] In some preferred embodiments, the fermentation substrate medium comprises water and the following components by weight-volume percentage: 1-4% corn flour, 0.2-1% soybean meal, 0.1-0.5% yeast peptone, 0.05-0.3% L-serine, 0.001-0.01% glycine, 0.1-1% sodium chloride, 0.1-0.4% calcium chloride, 0.05-0.2% potassium dihydrogen phosphate, 0.05-0.2% magnesium sulfate, and 0.002-0.0% sodium chloride. 1% zinc sulfate and 0.001-0.01% ferrous sulfate; in some specific embodiments, the fermentation base water culture medium comprises water and the following components by weight-volume percentage: 2% corn flour, 0.5% soybean meal, 0.1% yeast peptone (Angel FP103), 0.1% L-serine, 0.005% glycine, 0.6% sodium chloride, 0.2% calcium chloride, 0.1% potassium dihydrogen phosphate, 0.1% magnesium sulfate, 0.01% zinc sulfate and 0.005% ferrous sulfate.
[0016] In some specific embodiments, the pH of the fermentation bottom water culture medium may be 6.0, 6.1, or 6.2.
[0017] In some preferred embodiments, the feed 1 comprises water and any combination of the following components: a combination of 5-25% corn flour and 0.05-0.3% L-serine, a combination of 10-25% maltodextrin and 0.05-0.3% L-serine, or a combination of 10-25% glycerol and 0.05-0.3% L-serine, wherein the corn flour comprises liquefied corn flour and / or non-liquefied corn flour; the feed 2 is 5-10% soybean meal and the remainder water, or 1-3.5% ammonium sulfate and the remainder water; the feed 3 is 10-15% ammonia water. In some specific embodiments, supplement 1 comprises water and any combination selected from the following: a combination of 10% non-liquefied corn flour and 0.3% L-serine, a combination of 25% liquefied corn flour and 0.3% L-serine, a combination of 25% maltodextrin and 0.3% L-serine, or a combination of 25% glycerol and 0.3% L-serine; supplement 2 is 10% soybean meal and the remainder water, or 3.5% ammonium sulfate and the remainder water; supplement 3 is 15% ammonia. In the above supplements, the percentage "%" for each component is a mass-volume percentage, representing the proportion of each component in the supplement, in g / ml.
[0018] In some embodiments, the culture medium of the present invention further includes a bacterial slant culture medium; the bacterial slant culture medium comprises: soluble starch, yeast extract, yeast peptone, sodium chloride, agar, and water, with a pH of 6.0-6.2. Preferably, the bacterial slant culture medium comprises 1-3% soluble starch, 0.5-3% yeast extract, 0.2-1% yeast peptone, 0.1-1% sodium chloride, 2-3% agar, and the balance being water, with a pH of 6.0-6.2; in some specific embodiments, the bacterial slant culture medium comprises 2% soluble starch, 1% yeast extract, 0.4% yeast peptone, 1% sodium chloride, 3% agar, and the balance being water, with a pH of 6.2.
[0019] In some embodiments, the culture medium of the present invention further includes a primary seed culture medium; the primary seed culture medium includes soluble starch, yeast extract, yeast peptone, sodium chloride, potassium dihydrogen phosphate, magnesium sulfate, and water, with a pH of 6.0-6.2. Preferably, the primary seed culture medium includes 1-3% soluble starch, 0.5-3% yeast extract, 0.2-1% yeast peptone, 0.1-1% sodium chloride, 0.05-0.2% potassium dihydrogen phosphate, 0.05-0.2% magnesium sulfate, and the balance being water. In some specific embodiments, the primary seed culture medium includes 2% soluble starch, 1% yeast extract, 0.4% yeast peptone, 0.6% sodium chloride, 0.1% potassium dihydrogen phosphate, 0.1% magnesium sulfate, and the balance being water, with a pH of 6.2.
[0020] In some embodiments, the culture medium of the present invention further includes a secondary seed culture medium; the secondary seed culture medium includes corn flour, soybean flour, yeast extract, L-serine, glycine, potassium dihydrogen phosphate, magnesium sulfate, and water, with a pH of 6.0-6.2. In some preferred embodiments, the secondary seed culture medium includes 1-3% corn flour, 0.2-1% soybean flour, 0.1-0.5% yeast extract, 0.05-0.3% L-serine, 0.001-0.01% glycine, 0.05-0.2% potassium dihydrogen phosphate, 0.05-0.2% magnesium sulfate, with the balance being water, and a pH of 6.0-6.2. In some specific embodiments, the secondary seed culture comprises the following components by mass-volume percentage: 2% corn flour, 1% soybean flour, 0.2% yeast extract, 0.1% L-serine, 0.005% glycine, 0.1% potassium dihydrogen phosphate, 0.1% magnesium sulfate, with the balance being water, and pH 6.2.
[0021] The present invention also provides a fermentation method for Bacillus subtilis, comprising: performing fed-batch fermentation of Bacillus subtilis using the culture medium described in the present invention to obtain a fermentation broth; the fed-batch fermentation includes: inoculating the Bacillus subtilis into the fermentation bottom water culture medium described in the present invention, and adding the feedstock in a fed-batch manner. The specific timing of the feedstock addition is determined based on changes in dissolved oxygen and total sugar content. In a specific embodiment of the present invention, the feedstock is added 1-2 hours after inoculation into the fermentation bottom water culture medium.
[0022] In some embodiments, prior to the fed-batch fermentation, a step of scaling up the Bacillus subtilis culture using the strain slant culture medium, primary seed culture medium, and / or secondary seed culture medium described in this invention is included. In some specific embodiments, prior to the fed-batch fermentation, the following step is further included: scaling up the Bacillus subtilis culture using the strain slant culture medium described in this invention, or using the strain slant culture medium and primary seed culture medium described in this invention, or using the strain slant culture medium, primary seed culture medium, and secondary seed culture medium described in this invention.
[0023] In some embodiments, the initial fermentation temperature of the fed-batch fermentation is 36-45°C, the fermentation temperature increases by 1-2°C every 2-4 hours during the fermentation process, and the fermentation temperature is maintained at 46-52°C for subsequent fermentation after 12-16 hours, with a total fermentation cycle of 34-40 hours. In some specific embodiments, the initial fermentation temperature of the fed-batch fermentation is 42°C, the fermentation temperature increases by 2°C every 4 hours during the fermentation process, and the fermentation temperature is maintained at 50°C for subsequent fermentation after 16 hours, with a total fermentation cycle of 36-40 hours;
[0024] In some embodiments, the feed 1 is fed in a pulsed manner to maintain dissolved oxygen levels fluctuating between 10-30% during the fermentation process and to maintain a total sugar content of <30g / L, or the feed 2 is fed in a segmented, uniform manner to maintain dissolved oxygen levels of 30% and to maintain a total sugar content of 10-20g / L during the fermentation process; the feed 3 is used to control the fermentation pH to be constant at 6.0, or to control the fermentation pH to be >5.8. When the pH of the fermentation broth is lower than 5.8, ammonia is used to adjust the pH to 6.5.
[0025] In this invention, there are no special restrictions on the specific sources of the yeast protein and yeast extract powder; ordinary commercially available products are acceptable. In a specific embodiment of this invention, the yeast protein is Angel FP103, and the yeast extract powder is Angel FM888.
[0026] The present invention also provides a method for preparing nattokinase and / or vitamin K2, comprising the following steps: Step (1) The fermentation broth obtained by the fermentation method of the present invention is subjected to flocculation separation and plate and frame filtration in sequence, and the clear liquid and bacterial residue are collected respectively; Step (2) The clear liquid is concentrated after membrane filtration and dried to obtain a product rich in nattokinase; Step (3) The bacterial residue is dried to obtain a product rich in vitamin K2.
[0027] After obtaining products rich in nattokinase and vitamin K2 according to the above preparation method of the present invention, pure nattokinase and pure vitamin K2 can also be obtained by using the separation and purification methods disclosed in the art.
[0028] In some embodiments, in step (1), a flocculant and perlite are used to flocculate and separate the fermentation broth. In some specific embodiments, the flocculant is a composite clarifying flocculant, specifically polyacrylamide, calcium chloride, etc., any type commonly used in the art; the amount of perlite added is 2% of the total mass of the fermentation broth. In some specific embodiments, the flocculation and separation includes: first adding a composite clarifying flocculant to the fermentation broth until the concentration of the composite clarifying flocculant is 1.0 g / L, stirring at high speed for 2 h, and then adding 2.0 g / L of perlite.
[0029] In some embodiments, step (2) further includes mixing the concentrated liquid and excipients after concentration and before drying to obtain raw material containing nattokinase, wherein the drying is spray drying; in step (3), the step further includes mixing and granulating the bacterial residue and excipients before drying, wherein the drying is fluidized bed drying.
[0030] This invention provides a strain of Bacillus subtilis and its application in the co-production of nattokinase and vitamin K2. This strain enables simultaneous fermentation of nattokinase and vitamin K2, produces a rich enzyme system of proteases, has a short fermentation cycle, and low cost. The fermentation supernatant is mainly used to produce nattokinase-related products, and the separated heavy phase (bacterial sludge) is mainly used to produce vitamin K2-related products. This invention has the following advantages.
[0031] 1. The fermentation cycle of the strain of the present invention is <40 h. The nattokinase content in the fermentation broth is nearly 35% higher than the highest enzyme activity reported in the industry, and it is rich in a variety of protease systems. The temperature and acid resistance of the nattokinase produced by this strain is significantly improved, and the enzyme activity recovery rate of spray drying is nearly 80%, which effectively solves the problems of low fermentation level of nattokinase and large enzyme activity loss during spray drying in the industry.
[0032] 2. The vitamin K2 content in the by-product sludge (heavy phase) after fermentation of nattokinase by the strain of the present invention reaches more than 140 ug / g, which can be directly used as a raw material for vitamin K2 extraction. Due to the short fermentation cycle and high utilization value of the by-product, the problem of long fermentation cycle and high production cost of vitamin K2 is effectively solved.
[0033] Term Definitions
[0034] The “natto” mentioned in this invention is a soybean product made by fermenting soybeans with Bacillus subtilis natto.
[0035] The "nattokinase" mentioned in this invention is an alkaline serine protease extracted from natto, which has been reported in the prior art. The "nattokinase fermentation product" used in this invention refers to a fermentation product containing nattokinase.
[0036] The term “vitamin K2 fermentation product” as used in this invention refers to a fermentation product containing vitamin K2.
[0037] The “fermentation method of Bacillus subtilis” described in this invention also refers to a method of fermentation using Bacillus subtilis. For example, Bacillus subtilis RB4 of this invention is used to ferment a substrate (e.g., corn flour, soybean meal) to obtain a fermented product.
[0038] The "feed-feed fermentation" described in this invention, also known as fed-batch fermentation or semi-continuous fermentation, refers to a fermentation technique in which a certain amount of material is added to the fermentation system in a certain way during the batch fermentation process of microorganisms, but the fermentation broth is not continuously released. The "feed-feed addition" method used in this invention refers to adding feed in the manner of fed-feed fermentation, for example, in batch culture, feed is gradually added as fermentation progresses.
[0039] The “fermentation base water culture medium” mentioned in this invention refers to the culture medium used at the beginning of fermentation, and can also be called the fermentation base culture medium.
Implementation Method
[0041] This invention discloses a strain of Bacillus subtilis and its application in the co-production of nattokinase and vitamin K2. Those skilled in the art can refer to the content of this document and appropriately modify the process parameters to achieve the desired result. It should be particularly noted that all similar substitutions and modifications are obvious to those skilled in the art and are considered to be included in this invention. The methods and applications of this invention have been described through preferred embodiments. Those skilled in the art can obviously make modifications or appropriate changes and combinations to the methods and applications described herein without departing from the content, spirit, and scope of this invention to realize and apply the technology of this invention.
[0042] This invention isolated multiple Bacillus strains from traditional Baijiu cellar mud in Yibin, Sichuan Province. These strains underwent initial screening using fibrin plates and high-temperature acclimation. One strain, RB4, capable of growing well at 48-50℃, was selected. Finally, studies were conducted on the liquid fermentation of this strain to produce nattokinase, protease, and vitamin K2-related metabolites. The results showed that this strain exhibited outstanding performance in producing nattokinase and vitamin K2. Based on morphological and molecular biological (16S rDNA) analysis, it was identified as Bacillus subtilis. The 16S rDNA gene sequence of strain RB4 is as follows:
[0044] Unless otherwise specified, the concentration % of each component in the embodiments of the present invention are all mass-volume percentages (in g / ml).
[0045] The present invention will be further illustrated below with reference to the embodiments:
[0046] Example 1
[0047] Bacillus subtilis RB4 (accession number CCTCC NO: M 2024343) was cultured on slant, cultured as a primary seed culture, and fermented in a 50L tank. The nattokinase activity and vitamin K2 content of the fermentation broth were monitored and detected. The levels of nattokinase and vitamin K2 produced are shown in Tables 1 and 2.
[0048] The specific manufacturing process includes the following:
[0049] (1)Slant culture: The above strains were inoculated into strain slant culture medium, and the slant culture temperature was 42℃ and the time was 24h.
[0050] The formula of the slant culture medium is as follows: 2% soluble starch, 1% yeast extract powder (Angel FM888), 0.4% yeast peptone (Angel FP103), 1% sodium chloride, 3% agar, and the balance is water, pH 6.2, sterilized at 121℃ for 30 min.
[0051] (2)Primary seed culture: The strain cultured on the slant was inoculated into a 5L shake flask containing 1L of primary seed culture medium. The culture temperature was 42℃, the shaker speed was 220r / min, and the culture time was 20h to obtain the primary seed culture solution.
[0052] The formula for the primary seed culture medium is: 2% soluble starch, 1% yeast extract powder (Angel FM888), 0.4% yeast peptone (Angel FP103), 0.6% sodium chloride, 0.1% potassium dihydrogen phosphate, 0.1% magnesium sulfate, with the balance being water, pH 6.2, sterilized at 121℃ for 30 min.
[0053] (3)Feed fermentation: 1.2L of primary seed culture medium was inoculated into a 50L tank containing 6.8L of fermentation bottom water culture medium for fed fermentation. The fermentation program controlled the pH at 6.0, the fermentation temperature at 42℃, the fermentation tank rotation speed at 200-250r / min, and the aeration rate at 1:1~1.2:1 vvm. Feeding (including feed 1, feed 2 and feed 3) was started after 1~2h of culture.
[0054] The culture medium used in this process includes fermentation base water medium and feed. The fermentation base water medium consists of: 2% corn flour, 0.5% soybean meal, 0.1% yeast peptone (Angel FP103), 0.1% L-serine, 0.005% glycine, 0.6% sodium chloride, 0.2% calcium chloride, 0.1% potassium dihydrogen phosphate, 0.1% magnesium sulfate, 0.01% zinc sulfate, and 0.005% ferrous sulfate. Feed 1 consists of: 25% liquefied corn flour and 0.3% L-serine; Feed 2 consists of: 10% soybean meal; Feed 3 consists of: 15% ammonia water (used to adjust pH, added appropriately according to pH changes).
[0055] All raw materials used in this invention can be purchased from the market, and the same products from different brands can be substituted for each other.
[0056] The fed-batch fermentation process is as follows: the volume of feed 1 is 10L, and dissolved oxygen is added in a linked feeding manner to maintain dissolved oxygen at 30% and total sugar content at 10-20g / L. The total volume of feed 2 is 6L, and it is added in a segmented uniform flow rate. The flow rate of feed 2 is 65% of that of feed 1.
[0057] Sampling is performed periodically for centrifugation to detect nattokinase activity in the fermentation broth. High-pressure homogenization is used on the heavy phase to disrupt the cell wall and detect vitamin K2 content. Nattokinase activity reference: DBS44 / 013-2019 Local Food Safety Standard for Determination of Nattokinase in Natto Powder—Ultraviolet Spectrophotometry. Vitamin K2 content reference: Appendix A.4, Vitamin K2 Detection Method, Announcement No. 8 of the National Health and Family Planning Commission, 2016.
[0058] Test Example 1: Comparison of Fermentation Results of Different Microbial Strains
[0059] Using multiple Bacillus strains SD, YJ, RB1, RB2, MG1, MG3, SJ1, SJ2, BL1, and BL2 selected in the laboratory as research objects, Bacillus subtilis was cultured on slant, primary seed culture, secondary seed culture, and fed-batch fermentation in a 50L tank according to the following process. The nattokinase activity and heavy-phase vitamin K2 content of the fermentation broth were tracked and detected. The nattokinase and vitamin K2 levels produced by different strains are shown in Tables 1 and 2.
[0060] Comparative Examples 1-10 differed from Example 1 in that the main strains were different, while other processes remained unchanged.
[0061] Table 1 Comparison of nattokinase and fermentation time among different strains Example Nattokinase activity (FU / g) Acidic protease (U / g) Neutral protease (U / g) Alkaline protease (U / g) Optimal fermentation time (h) Example 1 (RB4) 1873 1106 4935 2848 38 Comparative Example 1 (SD) 1560 1413 2083 1971 47 Comparative Example 2 (YJ) 754 229 1321 890 53 Comparative Example 3 (RB1) 211 342 837 423 66 Comparative Example 4 (RB2) 1269 1211 1628 1363 60 Comparative Example 5 (MG1) 83 213 594 298 60 Comparative Example 6 (MG3) 950 335 3255 1554 48 Comparative Example 7 (SJ1) 671 201 2101 982 32 Comparative Example 8 (SJ2) 720 197 1898 1562 36 Comparative Example 9 (BL1) 39 302 761 338 68 Comparative Example 10 (BL2) 90 643 1032 775 72
[0062] Table 2 Comparison of Vitamin K2 and Fermentation Time in the Heavy Phase of Fermentation Broth from Different Strains Example Vitamin K2 (ug / g) Optimal fermentation time (h) Example 1 (RB4) 152 96 Comparative Example 1 (SD) 41 72 Comparative Example 2 (YJ) 138 120 Comparative Example 3 (RB1) 103 96 Comparative Example 4 (RB2) 156 168 Comparative Example 5 (MG1) 18 60 Comparative Example 6 (MG3) 90 108 Comparative Example 7 (SJ1) 62 168 Comparative Example 8 (SJ2) 26 70 Comparative Example 9 (BL) 39 68 Comparative Example 10 (YZ1) 80 108
[0063] As shown in Tables 1 and 2, the RB4 strain of the present invention exhibits outstanding fermentation performance of nattokinase and is rich in vitamin K2. This strain RB4 was deposited at the Food Industry Development Institute Foundation in 2025 with accession number CCTCC NO: M 2024343 (and deposited at the China Center for Type Culture Collection on February 27, 2024, at Wuhan University, Wuhan, China with accession number CCTCC NO: M 2024343).
[0064] Example 2
[0065] Unlike Example 1, Feeding 1 adopts a pulsed feeding method, maintaining dissolved oxygen fluctuations of 10-30% during the fermentation process, maintaining a total sugar content of <30g / L, and a fermentation time of 34-36h. Other processes remain unchanged.
[0066] Example 3
[0067] The difference from Example 2 is that feed 1 consists of 25% maltodextrin and 0.3% L-serine. Other processes remain unchanged.
[0068] Comparative Example 11
[0069] The difference from Example 2 is that feed 1 consists of 10% non-liquefied corn flour and 0.3% L-serine. Other processes remain unchanged.
[0070] Comparative Example 12
[0071] The difference from Example 2 is that the feed 1 is: 25% glucose, L-serine is added after sterilization, and the other processes remain unchanged.
[0072] Comparative Example 13
[0073] The difference from Example 2 is that feed 1 consists of 25% sucrose and 0.3% L-serine. Other processes remain unchanged.
[0074] Comparative Example 14
[0075] The difference from Example 2 is that feed 1 consists of 25% glycerol and 0.3% L-serine. Other processes remain unchanged.
[0076] Comparative Example 15
[0077] The difference from Example 2 is that the supplement 2 is 10% yeast protein powder. The other processes remain unchanged.
[0078] Comparative Example 16
[0079] The difference from Example 2 is that the feed 2 is 3.5% ammonium sulfate. The other processes remain unchanged.
[0080] Test Example 2: Comparison of Fermentation Results with Different Feeds
[0081] The nattokinase activity and vitamin K2 content in fermentation broths obtained from different feed fermentations were detected, and the results are shown in Table 3:
[0082] Table 3 Effects of different supplements on nattokinase activity and vitamin K2 content Group Nattokinase activity (FU / g) Vitamin K2 (ug / g) Example 2 2601 146 Example 3 2538 159 Comparative Example 11 1810 85 Comparative Example 12 629 161 Comparative Example 13 738 63 Comparative Example 14 1847 182 Comparative Example 15 198 79 Comparative Example 16 2337 142
[0083] As shown in Table 3, under different fermentation raw materials and fed-batch process parameters, the natto kinase activity and vitamin content of RB4 strain fermentation are quite different. When liquefied corn starch or dextrin is used as carbon source, soybean meal is used as nitrogen source, and pulse feeding process control is used, the natto kinase activity and vitamin K2 content of fermentation are relatively ideal. The average natto kinase activity of fermentation broth is >2500 FU / g, and the vitamin K2 content in the heavy phase is >140 ug / g.
[0084] Example 4
[0085] Unlike Example 2, in Feed 3, the fermentation pH was controlled to be >5.8. When the pH of the fermentation broth was lower than 5.8, ammonia was used to adjust the pH to 6.5 for control. The initial fermentation temperature was 42℃, and the fermentation temperature was increased by 2℃ every 4 hours during the fermentation process. After 16 hours of fermentation, the fermentation temperature was maintained at 50℃ for subsequent fermentation, while other processes remained unchanged. 0.1% of a compound clarifying flocculant was added to the fermentation broth in the tank, and the mixture was stirred at 500 r / min for 2 hours. 2% perlite was added, and the mixture was subjected to plate and frame filtration. The filtered liquid was concentrated 5-6 times by filtration through an 8000 Dalton membrane. The temperature was raised to 50℃, and 5% dextrin was added and stirred evenly. The mixture was then dried using a spray drying tower with an inlet air temperature of 110-120℃ and an outlet temperature of <70℃ to obtain raw material rich in nattokinase.
[0086] Comparative Example 17
[0087] The difference from Example 4 is that the fermentation temperature is maintained at 42°C, the fermentation pH is controlled at 6.0, and other processes remain unchanged.
[0088] Comparative Example 18
[0089] Unlike Example 4, the fermentation temperature was maintained at 42°C, while other processes remained unchanged.
[0090] Comparative Example 19
[0091] The difference from Example 4 is that the fermentation pH is controlled at 6.0, while other processes remain unchanged.
[0092] Comparative Example 20
[0093] Unlike Example 4, the fermentation temperature was maintained at 37°C and the fermentation pH was controlled at 6.0, while other processes remained unchanged.
[0094] Comparative Example 21
[0095] Unlike Example 4, the fermentation temperature was maintained at 50°C and the fermentation pH was controlled at 6.0, while other processes remained unchanged.
[0096] Test Example 3: Comparison of Fermentation Results of Different Processes
[0097] Table 4 Comparison of nattokinase activity and spray-drying enzyme activity yield under different process control Example Nattokinase activity (FU / g) Enzyme activity recovery rate (%) Example 4 (Variable Temperature, pH Fluctuations) 2763 76 Comparative Example 17 (constant temperature, constant pH) 2575 71 Comparative Example 18 (Isothermal, pH Fluctuation) 2598 75 Comparative Example 19 (variable temperature, constant pH) 2309 83 Comparative Example 20 (low temperature, constant pH) 2335 66 Comparative Example 21 (High Temperature, Constant pH) 1821 87
[0098] As shown in Table 4, under the variable temperature and pH fluctuation fermentation process control system in Example 4, the natto kinase activity of the fermentation broth reached a maximum of 2763 FU / g, and the spray enzyme activity yield was >75%. Compared with the constant temperature and constant pH fermentation control process, the natto kinase activity and spray enzyme activity yield of the fermentation broth were significantly improved.
[0099] The above description is only a preferred embodiment of the present invention, and of course it cannot be used to limit the scope of the present invention. It should be noted that for those skilled in the art, several improvements and modifications can be made without departing from the principle of the present invention, and these improvements and modifications are also considered to be within the scope of protection of the present invention. [Simplified Explanation of the Diagram]
[0040] None [Biomaterial Storage]
[0101] Domestic Storage Information 1. Republic of China, Food Industry Development Research Institute, Biological Resources Preservation and Research Center, 2025.XX.XX, CCTCC NO: M 2024343.
[0102] Foreign Deposit Information 1. China, China Center for Type Culture Collection, 2024.02.27, CCTCC NO: M 2024343.
Claims
1. A Bacillus subtilis strain, characterized by its registration number BCRC 911291.
2. A microbial inoculant, characterized in that it comprises Bacillus subtilis as described in claim 1.
3. The use of Bacillus subtilis as described in claim 1 in the preparation of nattokinase and / or vitamin K2.
4. The use of Bacillus subtilis as described in claim 1 in the preparation of nattokinase fermentation products and / or vitamin K2 fermentation products.
5. The use of Bacillus subtilis as described in claim 1 in the preparation of fermented black beans, natto, or natto powder.
6. The use of Bacillus subtilis as described in claim 1 in the preparation of intestinal probiotic agents.
7. The use of Bacillus subtilis as described in claim 1 in the preparation of biofeed.
8. A fermentation method for Bacillus subtilis, characterized in that it comprises: Bacillus subtilis as described in claim 1 was fed-batch fermentation using a fermentation bottom water culture medium and feed to obtain a fermentation broth; The fed-batch fermentation includes: inoculating the Bacillus subtilis into the fermentation bottom water culture medium, and adding the feedstock in a fed-batch manner; The fermentation substrate medium comprises water and the following components by weight-volume percentage: 1-4% corn flour, 0.2-1% soybean meal, 0.1-0.5% yeast peptone, 0.05-0.3% L-serine, 0.001-0.01% glycine, 0.1-1% sodium salt, 0.1-0.4% calcium salt, 0.05-0.2% potassium salt, 0.05-0.2% magnesium salt, 0.002-0.01% zinc salt, and 0.001-0.01% iron salt; the feed includes feed 1, feed 2, and feed 3; The feed 1 comprises water and a component selected from any combination of the following: a combination of 5-25% corn flour and 0.05-0.3% L-serine, a combination of 10-25% maltodextrin and 0.05-0.3% L-serine, or a combination of 10-25% glycerol and 0.05-0.3% L-serine; the corn flour comprises liquefied corn flour and / or non-liquefied corn flour; the feed 2 is 5-10% soybean meal and the balance water, or 1-3.5% ammonium sulfate and the balance water; the feed 3 is 10-15% ammonia water.
9. The fermentation method as described in claim 8, wherein, In the fermentation bottom water culture medium, the sodium salt includes sodium chloride; the calcium salt includes calcium chloride; the potassium salt includes potassium dihydrogen phosphate; the magnesium salt includes magnesium sulfate; the zinc salt includes zinc sulfate; and the iron salt includes ferrous sulfate.
10. The fermentation method as described in claim 8, wherein, Prior to fed-batch fermentation, the method further includes a step of scaling up the culture of Bacillus subtilis using strain slant culture medium, primary seed culture medium, and / or secondary seed culture medium.
11. The fermentation method as described in claim 10, wherein, The slant culture medium for the strain comprises: soluble starch, yeast extract, yeast peptone, sodium chloride, agar, and water, with a pH of 6.0–6.2; the primary seed culture medium comprises: soluble starch, yeast extract, yeast peptone, sodium chloride, potassium dihydrogen phosphate, magnesium sulfate, and water, with a pH of 6.0–6.2; the secondary seed culture medium comprises: corn flour, soybean flour, yeast extract, L-serine, glycine, potassium dihydrogen phosphate, magnesium sulfate, and water, with a pH of 6.0–6.
2.
12. The fermentation method as described in claim 8, wherein, The initial fermentation temperature of the fed-batch fermentation is 36~45℃. During the fermentation process, the fermentation temperature increases by 1~2℃ every 2~4 hours. After 12~16 hours of fermentation, the fermentation temperature is maintained at 46~52℃ for subsequent fermentation. The total fermentation cycle is 34~40 hours.
13. The fermentation method as described in claim 8, wherein, The feed 1 is fed in a pulsed manner to maintain dissolved oxygen levels fluctuating between 10-30% during fermentation and to maintain a total sugar content <30g / L, or a combined dissolved oxygen and dissolved oxygen feed 2 is fed in a segmented, uniform manner to maintain a total sugar content of 10-20g / L. The feed 3 is used to control the fermentation pH to be constant at 6.0, or to control the fermentation pH to be >5.
8. When the pH of the fermentation broth is lower than 5.8, ammonia is used to adjust the pH back to 6.
5.
14. A method for preparing a product containing nattokinase and / or vitamin K2, characterized by comprising the following steps: Step (1) performing the fermentation method as described in claim 8 to obtain a fermentation broth, and sequentially performing flocculation separation and plate and frame filtration on the obtained fermentation broth to collect the clear liquid and bacterial residue respectively; Step (2) concentrating and drying the clear liquid after membrane filtration to obtain a product rich in nattokinase; and Step (3) drying the bacterial residue to obtain a product rich in vitamin K2.
15. The preparation method as described in claim 14, wherein, In step (2), after concentration and before drying, the method further includes: mixing the concentrated liquid and excipients to obtain raw material containing nattokinase; the drying is spray drying; in step (3), before drying, the method further includes mixing the bacterial residue and excipients and granulating; the drying is fluidized bed drying.
Citation Information
Patent Citations
Method for simultaneously producing vitamin K2 and nattokinase through Bacillus natto fermentation
CN106701719A
